What does the Physician Payments Sunshine Act require manufacturers to report?

The Physician Payments Sunshine Act requires manufacturers of drugs, medical devices, and biological products to report certain payments and transfers of value made to physicians and teaching hospitals. This legislation is aimed at increasing transparency around financial relationships between healthcare providers and pharmaceutical or medical device companies, thereby helping to prevent potential conflicts of interest that may arise from these financial dealings.

As such, the correct answer encompasses both payments made to physicians and those made to teaching hospitals. This requirement ensures that stakeholders, including the public, have access to information about how much financial support healthcare providers are receiving from manufacturers. The intent behind this reporting is to promote accountability and integrity within the healthcare system, facilitating informed decisions by patients and policymakers about the trustworthiness of healthcare recommendations.